More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
APPAM Fall Research Conference 2026
Abt is a Gold Sponsor of APPAM 2026. Catch us in Boston, in our sessions and at booth 304, or connect with the team here!
National Association of Medicaid Directors (NAMD) Fall Conference 2026
Abt Global is a Sapphire sponsor of the NAMD 2026 Fall Conference. Find our Medicaid policy and data team at Booth 122.
With Win, Abt Global Extends Support for USACE Navigation Data Mission
Abt wins a seat on a USACE IDIQ supporting the data and analytics behind lock monitoring, dredging, and U.S. waterway statistics.
Insights from the City of Los Angeles’ Accessible Housing Program
Abt shares nine practical insights into what helps accessible housing programs succeed.